Taste and smell perception and quality of life during and after systemic therapy for breast cancer
- PMID: 29476290
- PMCID: PMC5993854
- DOI: 10.1007/s10549-018-4720-3
Taste and smell perception and quality of life during and after systemic therapy for breast cancer
Abstract
Purpose: The purpose of the study was to assess self-reported taste and smell perception after chemotherapy in breast cancer patients compared with women without cancer, and to assess whether taste and smell perception is associated with quality of life after the end of chemotherapy.
Methods: We included 135 newly diagnosed breast cancer patients who completed chemotherapy and 114 women without cancer. Questionnaires on taste, smell, and quality of life were completed shortly after and 6 months after chemotherapy (patients) or at two moments with 6 months' time window in between (comparisons).
Results: Self-reported taste and smell perception were significantly lower in patients shortly after chemotherapy compared to the comparison group. Most patients recovered 6 months after chemotherapy, although patients who were still receiving trastuzumab then reported a lower taste and smell perception compared to patients who were not. A lower self-reported taste and smell were statistically significantly associated with a worse quality of life, social, emotional, and role functioning shortly after chemotherapy. Six months after chemotherapy, taste and smell were statistically significantly associated with quality of life, social and role functioning, but only in patients receiving trastuzumab.
Conclusions: Most taste and smell alterations recovered within 6 months after the end of chemotherapy for breast cancer, but not for patients receiving trastuzumab. These results highlight the importance of monitoring taste and smell alterations during and after treatment with chemotherapy and trastuzumab, as they may impact quality of life.
Keywords: Breast cancer; Chemotherapy; Dysgeusia; Herceptin; Quality of life; Smell; Taste; Taste loss; Trastuzumab.
Conflict of interest statement
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in the study described in this manuscript were in accordance with the ethical standards of the institutional and/or national research committee.
Figures



Similar articles
-
Chemotherapy-induced taste and smell changes influence food perception in cancer patients.Support Care Cancer. 2021 Apr;29(4):2125-2132. doi: 10.1007/s00520-020-05717-1. Epub 2020 Sep 1. Support Care Cancer. 2021. PMID: 32870414
-
Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.Support Care Cancer. 2018 Dec;26(12):4077-4086. doi: 10.1007/s00520-018-4277-z. Epub 2018 May 31. Support Care Cancer. 2018. PMID: 29855774
-
The impact of taste and smell alterations on quality of life in head and neck cancer patients.Qual Life Res. 2016 Jun;25(6):1495-504. doi: 10.1007/s11136-015-1185-2. Epub 2015 Nov 20. Qual Life Res. 2016. PMID: 26589527
-
Disturbances of taste and smell induced by drugs.Pharmacotherapy. 1997 May-Jun;17(3):482-96. Pharmacotherapy. 1997. PMID: 9165552 Review.
-
Taste and smell disturbances in cancer patients: a scoping review of available treatments.Support Care Cancer. 2021 Jan;29(1):49-66. doi: 10.1007/s00520-020-05609-4. Epub 2020 Jul 30. Support Care Cancer. 2021. PMID: 32734392
Cited by
-
Investigating factors influencing subjective taste and smell alterations in colorectal cancer patients.Support Care Cancer. 2025 Feb 19;33(3):205. doi: 10.1007/s00520-025-09267-2. Support Care Cancer. 2025. PMID: 39971802
-
COVID-19 loss of taste and smell: potential psychological repercussions.Pan Afr Med J. 2022 Sep 21;43:38. doi: 10.11604/pamj.2022.43.38.31329. eCollection 2022. Pan Afr Med J. 2022. PMID: 36505013 Free PMC article. Review.
-
Sensory perceptions of survivors of cancer and their caregivers upon blinded evaluation of produce from two different sources.Support Care Cancer. 2021 Oct;29(10):5729-5739. doi: 10.1007/s00520-021-06090-3. Epub 2021 Mar 17. Support Care Cancer. 2021. PMID: 33728487 Free PMC article.
-
A protocol for a multidisciplinary early intervention during chemotherapy to improve dietary management behavior in breast cancer patients: a two-arm, single-center randomized controlled trial.BMC Cancer. 2024 Jul 18;24(1):859. doi: 10.1186/s12885-024-12623-w. BMC Cancer. 2024. PMID: 39026219 Free PMC article.
-
How much time is left? Associations between estimations of patient life expectancy and quality of life in patients and caregivers.Support Care Cancer. 2019 Jul;27(7):2487-2496. doi: 10.1007/s00520-018-4533-2. Epub 2018 Nov 1. Support Care Cancer. 2019. PMID: 30387051 Free PMC article.
References
-
- de Vries YC, Helmich E, Karsten MDA, Boesveldt S, Winkels RM, van Laarhoven HWM. The impact of chemosensory and food-related changes in patients with advanced oesophagogastric cancer treated with capecitabine and oxaliplatin: a qualitative study. Support Care Cancer. 2016;24(7):3119–3126. - PMC - PubMed
-
- Gamper EM, Giesinger JM, Oberguggenberger A, Kemmler G, Wintner LM, Gattringer K, Sperner-Unterweger B, Holzner B, Zabernigg A. Taste alterations in breast and gynaecological cancer patients receiving chemotherapy: prevalence, course of severity, and quality of life correlates. Acta Oncol. 2012;51(4):490–496. doi: 10.3109/0284186X.2011.633554. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical